Effect of reducing portion size at a compulsory meal on later energy intake, gut hormones, and appetite in overweight adults. by Lewis, HB et al.
1 
 
 
 
This is the author’s version of a work that was accepted for publication in Obesity. Changes resulting from the 
publishing process, such as peer review, editing, corrections, structural formatting and other quality control 
mechanisms may not be reflected in this document. Changes may have been made to this work since it was 
submitted for publication. 
 
Title 
The effect of covertly reducing food portion size at a single meal on daily energy intake and 
appetite control in overweight and obese adults. 
Authors 
Hannah B Lewis, Amy L Ahern, Ivonne Solis-Trapala, Celia G Walker, Frank Reimann, 
Fiona M Gribble and Susan A Jebb 
Affiliations 
Medical Research Council Human Nutrition Research, Cambridge, United Kingdom (HBL, 
ALA, IS-T, CGW, SAJ) 
Cambridge Institute for Medical Research, University of Cambridge, United Kingdom (FR, 
FMG) 
Keywords 
Portion size, appetite, gastrointestinal hormones, energy intake 
Running title 
Portion size reduction and appetite control 
Corresponding author 
2 
 
 
 
Hannah Lewis 
MRC Human Nutrition Research 
Elsie Widdowson Laboratory 
120 Fulbourn Road, Cambridge, CB1 9NL 
United Kingdom 
Tel:  +44 (0) 1223 426356 
Fax:  +44 (0) 1223 437515 
Email:  hbl23@cam.ac.uk 
3 
 
 
 
What is already known about this subject: 1 
• Larger portion sizes are linked with increased energy intake. 2 
• There is an innate asymmetry to the appetite control system. 3 
• There is a notable paucity of evidence on specifically reducing portion size in an 4 
overweight and obese population. 5 
What this study adds: 6 
• This study for the first time examines the effects of covert portion size reduction on 7 
later daily energy intake and appetite control in overweight and obese adults. 8 
• This study argues that covert portion size reduction could be a useful approach in 9 
attempts to constrain energy intake, particularly for weight gain prevention.  10 
Abstract 11 
Background: Larger portion sizes (PS) are associated with greater energy intake (EI), but 12 
little evidence exists on appetitive effects of PS reduction. 13 
Objective: To investigate covertly reducing breakfast PS on subsequent EI, postprandial 14 
gastrointestinal hormone and perceived appetite responses. 15 
Design: A randomized crossover study in 33 adults (mean BMI 29kg/m2). Condition A 16 
provided breakfast (25% of gender-specific estimated daily energy requirements); PS was 17 
then reduced by 20% (condition B) and 40% (condition C). EI was measured at an ad libitum 18 
lunch (240mins) and snack (360mins), and by weighed diet diaries (rest of the day). Blood 19 
was sampled after breakfast from 20 participants. Perceived appetite was measured using 20 
visual analogue scales.  21 
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Results:  Postprandial profiles of PYY, GLP-1, GIP, insulin and fullness were lower and 22 
hunger, desire to eat and prospective consumption higher in condition C compared to A.  23 
Despite this, EI at lunch (A:2930±203; B:2853±198; C:2911±179kJ) and later that day 24 
(A:3865±332; B:4011±369; C:3798±357kJ) did not differ. Hormones were not consistently 25 
associated with subsequent EI, but perceived appetite profiles were. 26 
Conclusions: Covert PS reduction does not lead to subsequent energy compensation that day, 27 
suggesting it could constrain daily EI.  Further research is required given altered perceived 28 
appetite and gastrointestinal hormones responses.   29 
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Introduction 30 
Concurrent with increasing prevalence of obesity has been increased mass of food consumed 31 
per eating occasion (1-3) and the size of commercially available portions (4-6).  Empirical 32 
evidence shows larger portion sizes (PS) lead to greater energy intake (EI) at a single meal; an 33 
effect that continues with 11 days of manipulation (7-15). Reducing PS is a central 34 
component in weight management advice, but experimental work to investigate whether PS 35 
reduction leads to reduced EI is limited (7-15).  Given the asymmetry of appetite and 36 
homeostatic mechanisms to achieve energy balance (16), energy compensation may occur in 37 
an environment where food is widely available.  Understanding the response of short-term 38 
appetite control mechanisms to a PS reduction is important to understand the likely impact on 39 
EI.  40 
This study investigated whether covertly reducing the PS of a meal is an effective strategy to 41 
reduce day-long EI in overweight and obese adults and the impact on gastrointestinal 42 
hormones and perceived appetite as measures of biological and psychological appetite control 43 
mechanisms. 44 
Methods 45 
Study Design 46 
This was a randomised crossover design involving three PS conditions, presented to each 47 
participant at a standardised breakfast time on separate days: a control PS (condition A); PS 48 
reduced by 20% (condition B); and PS reduced by 40% (condition C).  The control provided 49 
25% of estimated daily energy requirements for the intended average study participant 50 
according to gender (24), (3310kJ for men and 2540kJ for women).  Participants were blinded 51 
to the specific aims of the study and foods prepared to make the intervention as covert as 52 
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possible.  For each individual, study visits were conducted >1 week apart, on the same day of 53 
the week and outside of the luteal phase of the menstrual cycle for females.   54 
Participants 55 
Healthy, 18-60y men and women, with a BMI ≥25 and <35kg/m2 were recruited.  Participants 56 
were excluded for disordered eating assessed with Eating Attitudes Test (EAT-26) score ≥11 57 
(17-19), depressive symptoms using the Zung Depression Scale score ≥70 (20), smoking, 58 
excessive habitual alcohol intake (>14 units/week for women, >21 units/week for men), 59 
weight loss/gain within the last three months (>4.5kg) or actively trying to lose/gain weight, 60 
medical conditions or medications potentially affecting appetite, inflammatory conditions, 61 
diabetes or fasting plasma glucose ≥7mmol/l, pregnancy, breastfeeding or planning a 62 
pregnancy, extremely high levels of exercise (moderate or vigorous level for more than 63 
420min/week assessed with International Physical Activity Questionnaire (IPAQ) (21)), 64 
unable to eat test foods, and not regularly consuming breakfast (breakfast ≤3/week). 65 
A sample size of 33 was recruited to give 83% power to detect a minimum difference of 66 
500kJ EI at lunch between any pair of experimental conditions assuming an SD of 950kJ 67 
(8,10,22).  Biochemical measures were conducted in a sub-group of 20 participants.  68 
Recruitment and screening 69 
Participants were recruited from the community, for a study investigating the “relationship 70 
between diet and metabolism”.  Height, weight, waist circumference, body composition 71 
(Tanita body composition analyser BC-418MA), and resting metabolic rate (RMR; IS Gem 72 
204 with GEMNutrition 2008.4 software) were measured.  Participants completed the EAT-73 
26, Zung depression scale, IPAQ and the Three Factor Eating Questionnaire (TFEQ) 74 
measuring the traits dietary restraint, disinhibition, and hunger (23) and fasting plasma 75 
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glucose assessed.  Participants were asked to maintain their usual exercise and dietary habits 76 
during the study.  77 
Study visits 78 
Participants fasted overnight (11h prior to each visit) and were asked to refrain from alcohol 79 
and avoid strenuous exercise for the 24h before each study day. Provision of the test breakfast 80 
marked time zero.  Subsequent EI was measured by pre- and post-meal weighing of an ad 81 
libitum lunch (240min) and afternoon snack (360min), plus a weighed diet diary to record the 82 
remainder of the day’s intake.  Visual analogue scale (VAS) questionnaires rating palatability 83 
and meal size were given during breakfast and lunch.  Perceived appetite ratings were 84 
measured using VAS questionnaires at 30min intervals until lunch, then immediately after 85 
and at 300 and 360min, then hourly.  In a subgroup of 20 participants, blood samples were 86 
collected at fasting and 30, 60, 120, 180 and 240min for the analysis of peptide tyrosine 87 
tyrosine 3-36 (PYY3-36), total glucagon-like peptide-1 (GLP-1), total glucose-dependent 88 
insulinotropic peptide (GIP), glucose and insulin (Figure 1). 89 
At the end of the study participants were fully debriefed on the study aims, reimbursed for 90 
travel expenses and given an honorarium.  Ethical approval for the study was obtained from 91 
Cambridgeshire 2 Research Ethics Committee in November 2010 (Ref: 10/H0308/99) and 92 
participants gave informed written consent.  The study was conducted at Medical Research 93 
Council Human Nutrition Research (MRC HNR) between January 2011 and September 2012.   94 
Study foods 95 
The study breakfast and lunch provided the average reported macronutrient composition of 96 
the UK diet (35% energy from fat, 18% from protein and 47% from carbohydrates (25)).  The 97 
breakfast consisted of a wheat-based breakfast cereal with semi-skimmed milk, scrambled 98 
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egg, ham, brown toast and butter, and orange juice.  The ad libitum lunch consisted of a single 99 
course amorphous meal of pasta, mince, tomato sauce, mixed vegetables and grated cheese.  100 
The lunch provided 1978kJ (men) or 1518kJ (women).  The ad libitum snack consisted of ten 101 
digestive biscuits on a plate. 102 
The completed diet diaries and recorded consumption at lunch and snack for each study day 103 
were coded by the Dietary Assessment Team at HNR using the in-house dietary assessment 104 
system. Dietary data was then extracted from the system for analysis. 105 
Questionnaires 106 
The mood and appetite VAS questionnaires rated hunger, fullness, desire to eat and 107 
prospective consumption, and also included five distractor questions.  The palatability 108 
questionnaire used VAS to rate the pleasantness of the food appearance, aroma, taste and 109 
texture, desire to eat the food, and the size of the portion.  The VAS questionnaires asked 110 
participants to mark a horizontal line measuring 100mm with the ends labelled with the 111 
extremes of each sensation (e.g. “Not at all” and “Extremely”).  The distance from the left end 112 
to where the participant mark was drawn was measured to the nearest millimetre.   113 
Analytic methods 114 
Blood samples were separated on collection and plasma stored at -80oC until analysis.  115 
Plasma samples collected on EDTA and treated with dipeptidyl peptidase-IV (DPP-IV) 116 
inhibitor immediately on collection (10µl DPP-IV inhibitor/ml of blood) were analysed for 117 
PYY3-36 by radioimmunoassay (Millipore®, Massachusetts, USA) (interassay CVs: 15% at 118 
84pg/ml and 7% at 217pg/ml), at University College Hospital, London; total GLP-1 using an 119 
electrochemical luminescence immunoassay kit on the MesoScale Discovery® multi-array 120 
assay platform (Maryland, USA) (CVs: 16.4% at 5.4pg/ml, 11.9% at 29pg/ml and 11.6% at 121 
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83pg/ml), at Core Biochemical Assay Laboratory (CBAL), Cambridge; and total GIP using an 122 
enzyme-linked immunosorbent assay (Millipore®, Massachusetts, USA) (CVs: 6.1% at 123 
26pg/ml, 3.3% at 50pg/ml, 2.3% at 134pg/ml and 1.8% at 166pg/ml), at Cambridge Institute 124 
for Medical Research.  Plasma samples collected on fluoride oxalate were analysed for 125 
glucose using a Dimension® clinical chemistry system (Siemens, Newark, USA) (CVs: 1.69% 126 
at 6.23mmol/L, 2.23% at 3.09mmol/L and 2.56% at 18.88mmol/L), at MRC HNR.  Plasma 127 
collected on lithium heparin were analysed for insulin on a 1235 AutoDELFIA® automatic 128 
immunoassay analyzer using a two-step time resolved fluorometric assay (Perkin Elmer Life 129 
Sciences, Wallac Oy, Turku, Finland) (CVs: 3.1% at 29pmol/L, 2.1% at 79.4pmol/L, 1.9% at 130 
277pmol/L and 2.0% at 705pmol/L) at CBAL, Cambridge.   131 
Statistical analysis 132 
Mixed effects models for continuous responses (26) were used for analysis, which extend 133 
standard linear regression to account for within-person variation through random effects.  EI 134 
and perceived PS at breakfast were modelled with PS condition as the explanatory variable, 135 
controlling for gender and BMI.  Dietary restraint, disinhibition and hunger, were tested for 136 
inclusion as covariates, but were omitted for no effects on the associations of interest.  137 
The effect of PS condition on biochemical measures and perceived appetite ratings was 138 
assessed by the interaction between condition and time, which estimated differences at each 139 
time point.  Area under the curve (AUC) was calculated using the trapezoidal rule for the time 140 
periods of fasting to the pre-lunch time-point for biochemical measures and perceived appetite 141 
ratings, and over the whole day for perceived appetite ratings.  Models of whole-day 142 
perceived appetite AUC included PS condition as the explanatory variable, controlling for 143 
time over which appetite ratings were made. 144 
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Models predicting EI at lunch included explanatory variables of either the pre-lunch or AUC 145 
for each biochemical measure or perceived appetite rating, and controlled for condition, 146 
gender and BMI.  Similar models assessed the relationship between the whole-day AUC of 147 
perceived appetite rating with whole day EI (except breakfast), also controlling for time over 148 
which appetite ratings were made. 149 
To examine the relationship between biochemical measures and perceived appetite, perceived 150 
appetite ratings were modelled separately with each biochemical measure as the explanatory 151 
variable.  Time, a quadratic term for time, condition, gender and BMI were included as 152 
covariates. 153 
Potential carry-over and sequence effects, gender, BMI and age, unless specified above as 154 
included a priori, were omitted as covariates as there were no effects on the associations of 155 
interest.  To account for correlation induced by multiple observations/individual (three visits), 156 
a random intercept was incorporated into the models.  The models for biochemical and 157 
perceived appetite profiles as outcomes had two levels of clustering due to repeated sampling 158 
time-points and the crossover design.  Therefore, a random intercept and a random slope for 159 
time were added to model within-individual variation.  Models were fitted using maximum 160 
likelihood estimation and likelihood ratio tests were used for model comparison.  Plots of 161 
residuals were used to check the goodness of fit for each outcome.  Insulin and GIP data were 162 
transformed (natural logarithm and square root respectively) for analyses, for a symmetrical 163 
distribution.  All analyses used STATA®12.0 software (StataCorp, Texas, USA).  Statistical 164 
significance was set at p<0.05.  Data are presented as mean±SEM unless indicated otherwise. 165 
Results 166 
Participant characteristics 167 
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The characteristics of the study participants are shown in Table 1.   168 
Energy intake (EI) 169 
EI was not different between conditions at lunch (Figure 2A; A vs. B, β=-76.6, p=0.429; B 170 
vs. C, β=58.2, p=0.547; A vs. C, β=-18.3, p=0.850), or the remainder of the day (Figure 2B; 171 
A vs. B, β=192.3, p=0.555; B vs. C, β=-152.8, p=0.639; A vs. C, β=39.5, p=0.904). Daily EI 172 
was 10287 ± 395kJ, 9897 ± 491kJ and 9161 ± 437kJ in conditions A, B and C respectively.  173 
Biochemical measures 174 
Figure 3 shows the postprandial profiles for each of the gastrointestinal hormones.  175 
Compared to condition A, there was a reduction in PYY in C at 120min (β=-22.05, p=0.022), 176 
and 240min (β=-23.9, p=0.013).  There was no condition-time interaction for conditions C 177 
compared to B (p>0.076), or B compared to A (p>0.42).  Compared to condition A, GLP-1 178 
was lower in C at 30 (β=-4.4, p=0.024), 60 (β=-4.2, p=0.032), 120 (β=-5.1, p=0.009), 180 179 
(β=-7.8, p<0.001), and 240min (β=-6.1, p=0.002).  GLP-1 was also lower in condition C 180 
compared to B at 180min (β=-4.1, p=0.038).  There was no condition-time interaction for 181 
condition B compared to A (p>0.056).  GIP was lower in condition B compared to A at 120 182 
(β=-1.6, p=0.014), 180 (β=-2.3, p<0.001) and 240min (β=-2.5, p<0.001).  GIP was lower in 183 
condition C compared to A at 30 (β=-2.2, p=0.001), 60 (β=-2.4, p<0.001), 120 (β=-4.2, 184 
p<0.001), 180 (β=-5.5, p<0.001) and 240min (β=-4.6, p<0.001), and compared to B at 30 (β=-185 
1.3, p=0.046), 120 (β=-2.6, p<0.001), 180 (β=-3.2, p<0.001)  and 240min (β=-2.0, p<0.001).   186 
Glucose and insulin profiles are shown in Figure 4.  There was no condition-time interaction 187 
for glucose for condition B compared to A (p>0.224), condition C compared to A (p>0.655) 188 
or condition C compared to B (p>0.210).  There was a condition-time interaction such that 189 
insulin was less in condition C compared to A at 120 (β=-0.7, p<0.001), 180 (β=-0.7, 190 
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p<0.001), and 240min (β=-0.4, p=0.008), and insulin was also less in condition C compared 191 
to B at 120 (β=-0.5, p=0.001), and 180min (β=-0.4, p=0.014).  There was no condition-time 192 
interaction for condition B compared to A (p>0.083). 193 
Perceived appetite ratings 194 
Figure 5 shows the perceived appetite ratings.  Compared to condition A, hunger was greater 195 
in C at all time-points from 30-240min (p<0.006).  Hunger was also greater in condition C at 196 
all time-points postprandially (p<0.021) when compared to B.  There was no condition-time 197 
interaction for condition B compared to A (p>0.291).  Compared to condition A, fullness was 198 
lower in C at all time-points from 20-180min (p<0.019).  Fullness was lower in condition C at 199 
30 (p=0.017) and 90min (p=0.003) when compared to B.  Also fullness was lower in 200 
condition B compared to A at 60 (p=0.041) and 120min (p=0.040).  Desire to eat ratings were 201 
greater in condition C at all time-points postprandially (p<0.023) compared to A, and at all 202 
time-points from 20-210min (p<0.037) compared to B.  There was no condition-time 203 
interaction for condition B compared to A (p>0.223).  Prospective consumption was greater in 204 
condition C compared to A at all time-points postprandially (p<0.011) and compared to B, at 205 
120 (p=0.018) and 150min (p=0.027).  There was no condition-time interaction for condition 206 
B compared to A (p>0.068).   207 
AUCs over the whole day for hunger, desire to eat and prospective consumption were greater 208 
in condition C compared to A, and smaller for fullness (hunger β=2423.9, p=0.025; fullness 209 
β=-4857.9, p=0.001; desire to eat β=3832.5, p=0.001; prospective consumption β=3427.9, 210 
p=0.001).  AUC for prospective consumption ratings was greater in condition B compared to 211 
A (β=2284.1, p=0.025), but AUC for hunger (p=0.232), fullness (p=0.136), and desire to eat 212 
(p=0.118) did not differ.  There were no differences in hunger or fullness when comparing 213 
conditions B and C (data not shown). 214 
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Predictors of energy intake (EI) at lunch and over the whole day 215 
Most of the biochemical measures did not predict EI at lunch (p>0.137) (Table 2).  However, 216 
AUC (p=0.032) and pre-lunch (p=0.049) measures of PYY were positively associated with EI 217 
at lunch.  AUCs and pre-lunch measures of hunger, desire to eat and prospective consumption 218 
were positively associated with lunch EI (p<0.02).  Pre-lunch fullness was negatively 219 
associated with lunch EI (p<0.002), but fullness AUC was not (p=0.085). AUCs for hunger, 220 
desire to eat and prospective consumption, but not fullness (p=0.469), were positively 221 
associated with EI over the day (p<0.026). 222 
Associations between biochemical measures and perceived appetite ratings 223 
GLP-1, GIP, glucose and insulin were negatively associated with hunger, desire to eat, and 224 
prospective consumption, and positively associated with fullness (p<0.012).  PYY was not 225 
associated with any of the perceived appetite ratings (p>0.068) (Table 3).  226 
Perceived portion size (PS) 227 
At debriefing, none of the participants were concerned about the study’s covert nature and 228 
consented to data inclusion.  Only two participants noticed the change in PS at breakfast.  229 
However the ratings of perceived meal size at breakfast were different between conditions.  230 
Perceived breakfast size was smaller in condition C compared to both A (β=-15.6, p<0.001) 231 
and B (β=-10.8, p<0.001), and perceived meal size smaller in B compared to A (data not 232 
shown). 233 
Discussion 234 
Reducing PS at a single meal alters psychological and biological markers of appetite, but 235 
there is no energy compensation later in the day.  EIs at lunch were strikingly consistent in 236 
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this standardized laboratory setting.  These findings indicate covertly reducing PS of a 237 
prepared meal could lead to a net reduction in daily EI.  However, the effect on perceived 238 
appetite and gastrointestinal hormones, particularly after the 40% reduction in PS questions 239 
the sustainability of this strategy to constrain EI. 240 
There were very few differences in the profiles for PYY and GLP-1 between the standard PS 241 
and the 20% reduction.  Moreover, there were few differences in the profiles when comparing 242 
the 20% and 40% reduction conditions suggesting that the responses in these biochemical 243 
measures may not be sensitive to the smaller change in PS (660kJ men and 510kJ women).  244 
Indeed, all previous studies where a reduction in energy load has led to attenuated PYY 245 
(27,28), GLP-1 (29,30), or insulin (31,32) profiles, used energy changes between 920-2096kJ.  246 
However, the present study showed distinct differences between all conditions in the 247 
postprandial profiles for GIP showing that it is sensitive to energy changes in a clear dose 248 
response manner, reflecting its important role as an incretin hormone for the regulation of 249 
insulin secretion. 250 
Interestingly, the ratings of perceived PS of the breakfast were different between conditions, 251 
although at debriefing most participants reported not noticing the meal manipulation.  The 252 
effect size for the difference between perceived PS ratings was considerably smaller when 253 
comparing conditions A versus B than B versus C (β=-4.8; β=-10.8), although the absolute 254 
difference in energy was the same.  This difference is likely due to either the relative 255 
difference between PS being different (20% A-B, and 25% B-C), or due to the Weber-256 
Fechner law, whereby the ability to perceive stimulus change is proportional to the logarithm 257 
of the magnitude of the stimulus (33).  Thus, as the reference portion size in the first 258 
comparison (A versus B) was larger than the second (B versus C), the change in PS detectable 259 
for the first pairing would have been larger than the second.  It is possible that the perception 260 
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of how much energy is provided, and thus consumed, could affect appetite ratings.  The 261 
smaller effect size of perceived PS between conditions A and B could in part account for 262 
fewer differences in perceived appetite ratings between these conditions. 263 
Postprandial biochemical responses were poor predictors of subsequent EI, consistent with 264 
much of the existing evidence (34-36).  However, perceived appetite ratings tended to predict 265 
EI at lunch and the rest of the day.  This is in agreement with some (22, 37-39), but not all 266 
(40,41), previous studies.  The mixed evidence likely reflects the subjective nature of the 267 
perception of appetite which leads to measurement variability, but differences are more easily 268 
detected in crossover than parallel design studies (42).  Although associations between 269 
perceived appetite and EI in the present study were highly significant, the effect sizes were 270 
small.  This, coupled with relatively small differences in postprandial perceived appetite 271 
response to the manipulated meal, could in part explain the lack of compensation for the 272 
changes in energy.  In contrast with the known function of PYY, where exogenous 273 
administration reduces EI (27, 43, 44), there was a small but significant positive effect of 274 
AUC and pre-lunch PYY on subsequent EI.  However, the effect decreased after adjustment 275 
for additional participant characteristics, indicating it may be confounded by other factors.  276 
Thus there is uncertainty about these present findings relating PYY.  In contrast to the clear 277 
exogenous effect, endogenous postprandial responses in PYY were not associated with 278 
subsequent EI (22,35,45), possibly as exogenous PYY tends to be supra-physiological (22).  279 
GLP-1, glucose and insulin were positively related to fullness and negatively related to 280 
hunger, desire to eat and prospective consumption consistent with previous research 281 
(32,34,46-49), indicating that these biochemical measures are likely to play roles in the 282 
perception of appetite sensations.  However, some studies have found no relationship, or 283 
mixed results, between glucose or insulin and perceived appetite ratings (34,39), possibly 284 
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because they have reported correlations between the mean AUC or peak values rather than 285 
examining within-person relationships.  Previous findings with respect to the relationship 286 
between postprandial PYY and perceived appetite are mixed, including positive associations 287 
between PYY and perceived fullness (46,50), while others, consistent with the present 288 
findings, have found no associations (22,49,51), or associations in lean but not obese 289 
participants (45).  Thus, the robustness of the association of endogenous PYY with perceived 290 
appetite is questionable.  It is unclear whether GIP plays a role in influencing appetite and EI 291 
(52), however the present findings showed GIP was associated with perceived appetite 292 
ratings.  The distinct similarity between GIP and perceived appetite profiles may have led to 293 
these associations, but causality cannot be assumed.  The lack of association between GIP and 294 
subsequent lunch EI is in agreement with the perspective that GIP does not influence EI. 295 
The present findings support the concept that covertly reducing the PS of commercially 296 
available unit foods or pre-prepared meals could constrain EI and contribute to prevention of 297 
weight gain.  However as weight control advice is inherently overt, it is important to establish 298 
whether similar effects are seen when participants are aware of the reduction in PS.   299 
There are several limitations to this study.  It was conducted in a laboratory setting and, 300 
although the specific hypothesis was concealed, participants were aware of their eating 301 
behaviour being observed.  The frequency and type of food provided at lunch was fixed, thus 302 
only the amount could vary potentially limiting compensation by removing some of the 303 
environmental cues that are profuse in a free-living environment and can influence EI.  This 304 
setting also prevented any self-initiated eating episodes between breakfast and lunch.  Some 305 
of the appetite and hormone profiles suggest effects of PS reduction may have diminished 306 
over time and compensation might be seen in a free-living environment during this period.  307 
The study was conducted over a single day and it is possible that a longer period of 308 
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consuming PSs set to provide energy below requirements could lead to adaptation and energy 309 
compensation.  Future studies should attempt to examine PS reduction in a more realistic 310 
setting and with prolonged exposure to smaller portions. 311 
Conclusions 312 
Covert reductions in PS lead to lower EI, despite changes in biological and behavioural 313 
measures that tend to favour energy compensation.  Although the effect size is small, if 314 
sustained this will be of public health benefit, in the prevention of weight gain.  315 
Conflict of interest 316 
SAJ is the independent Chair of the Department of Health Responsibility Deal Food Network 317 
in England, which includes voluntary agreements with industry to reduce the portion size of 318 
some food and drinks.  No other authors declare a conflict of interest.  319 
Acknowledgements 320 
HBL and SAJ were responsible for project conception. HBL, ALA and SAJ developed the 321 
protocol. IS-T advised on statistical analysis. HBL conducted research, analysed data, 322 
interpreted results, and drafted the manuscript. ALA, IS-T, CGW, FR, FMG and SAJ 323 
contributed to the data interpretation and critical revision of the manuscript. HBL had primary 324 
responsibility for final content. All authors read and approved the final manuscript.  325 
We thank the volunteers who participated in the study and the placement students and 326 
research assistants who assisted with data collection.  Thank you to Johannes Grosse for 327 
discussion and enabling GLP-1 analysis.  Thank you to JJ Laboratory Services, London for 328 
analysis of PYY; Core Biochemical Assay Laboratory, Department of Clinical Biochemistry, 329 
Cambridge for analysis of insulin and GIP; and the MRC HNR Nutritional Biomarker 330 
18 
 
 
 
Analysis team for analysis of glucose.  We also thank the MRC HNR dietary assessment team 331 
for their contribution to coding the diet diaries and the Biochemistry and Immunology 332 
Department at Cambridge University Hospitals NHS Foundation Trust for analysis of fasting 333 
plasma glucose at screening. This study was supported by a programme grant from the UK 334 
Medical Research Council (U105960389).  Analysis of GLP-1 was funded by Takeda 335 
Cambridge Ltd., UK. 336 
 
References 
1. Nielsen, S.J., Popkin, B.M. Patterns and trends in food portion sizes, 1977-1998. 
Journal of the American Medical Association 2003; 289(4):450-453. 
2. Smiciklas-Wright, H., Mitchell, D.C., Mickle, S.J., Goldman, J.D., Cook, A. Foods 
commonly eaten in the United States, 1989-1991 and 1994-1996: Are portion sizes 
changing? Journal of the American Dietetic Association 2003; 103(1):41-47. 
3. Kant, A.K., Graubard, B.I. Secular trends in patterns of self-reported food 
consumption of adult Americans: NHANES 1971-1975 to NHANES 1999-2002. 
American Journal of Clinical Nutrition 2006; 84(5):1215-1223. 
4. Young, L.R., Nestle, M. The contribution of expanding portion sizes to the US obesity 
epidemic. American Journal of Public Health 2002; 92(2):246-249. 
5. Young, L.R., Nestle, M. Expanding portion sizes in the US marketplace: Implications 
for nutrition counseling. Journal of the American Dietetic Association 2003; 
103(2):231-234. 
6. Matthiessen, J., Fagt, S., Biltoft-Jensen, A., Beck, A.M., Ovesen, L. Size makes a 
difference. Public Health Nutrition 2003; 6(1):65-72. 
19 
 
 
 
7. Levitsky, D.A., Youn, T. The more food young adults are served, the more they 
overeat. Journal of Nutrition 2004; 134(10):2546-2549. 
8. Rolls, B.J., Morris, E.L., Roe, L.S. Portion size of food affects energy intake in 
normal-weight and overweight men and women. American Journal of Clinical 
Nutrition 2002; 76(6):1207-1213. 
9. Rolls, B.J., Roe, L.S., Meengs, J.S., Wall, D.E. Increasing the portion size of a 
sandwich increases energy intake. Journal of the American Dietetic Association 2004; 
104(3):367-372. 
10. Kral, T.V.E., Roe, L.S., Rolls, B.J. Combined effects of energy density and portion 
size on energy intake in women. American Journal of Clinical Nutrition 2004; 
79(6):962-968. 
11. Kelly, M.T., Wallace, J.M.W., Robson, P.J., Rennie, K.L., Welch, R.W., Hannon-
Fletcher, M.P., Brennan, S., Fletcher, A., Livingstone, M.B.E. Increased portion size 
leads to a sustained increase in energy intake over 4d in normal-weight and 
overweight men and women. British Journal of Nutrition 2009; 102(3):470-477. 
12. Rolls, B.J., Roe, L.S., Meengs, J.S. Reductions in portion size and energy density of 
foods are additive and lead to sustained decreases in energy intake. American Journal 
of Clinical Nutrition 2006; 83(1):11-17. 
13. Rolls, B.J., Roe, L.S., Meengs, J.S. The effect of large portion sizes on energy intake 
is sustained for 11 days. Obesity 2007; 15(6):1535-1543. 
14. Rolls, B.J., Roe, L.S., Meengs, J.S. Larger portion sizes lead to a sustained increase in 
energy intake over 2 days. Journal of the American Dietetic Association 2006; 
106(4):543-549. 
20 
 
 
 
15. Jeffery, R.W., Rydell, S., Dunn, C.L., Harnack, L.J., Levine, A.S., Pentel, P.R., 
Baxter, J.E., Walsh, E.M. Effects of portion size on chronic energy intake. 
International Journal of Behavioral Nutrition and Physical Activity 2007; 4:27. 
16. Prentice, A., Jebb, S. Energy intake/physical activity interactions in the homeostasis of 
body weight regulation. Nutrition Reviews 2004; 62(7):S98-S104. 
17. Garner, D.M., Garfinkel, P.E. The Eating Attitudes Test: an index of the symptoms of 
anorexia nervosa. Psychological Medicine 1979; 9(2):273-279. 
18. Garner, D.M., Olmsted, M.P., Bohr, Y., Garfinkel, P.E. The Eating Attitudes Test: 
psychometric features and clinical correlates. Psychological Medicine 1982; 
12(4):871-878. 
19. Orbitello, B., Ciano, R., Corsaro, M., Rocco, P.L., Taboga, C., Tonutti, L., Armellini, 
M., Balestrieri, M. The EAT-26 as screening instrument for clinical nutrition unit 
attenders. International Journal of Obesity 2006; 30(6):977-981. 
20. Zung, W.W.K. A self-rating depression scale. Archives of General Psychiatry 1965; 
12(1):63-70. 
21. The IPAQ Group. International Physical Activity Questionnaire. Internet: 
https://sites.google.com/site/theipaq/ (accessed 1 April 2010). 
22. Doucet, E., Laviolette, M., Imbeault, P., Strychar, I., Rabasa-Lhoret, R., Prud'homme, 
D. Total peptide YY is a correlate of postprandial energy expenditure but not of 
appetite or energy intake in healthy women. Metabolism: Clinical and Experimental 
2008; 57(10):1458-1464. 
23. Stunkard, A.J., Messick, S. The three-factor eating questionnaire to measure dietary 
restraint, disinhibition and hunger. Journal of Psychosomatic Research 1985; 
29(1):71-83. 
21 
 
 
 
24. Scientific Advisory Committee on Nutrition. Dietary Reference Values for Energy.  
London: TSO; 2011. Internet: 
http://www.sacn.gov.uk/reports_position_statements/reports/sacn_dietary_reference_v
alues_for_energy.html (accessed 1 April 2012). 
25. National Diet and Nutrition Survey: Headline results from Year 1 of the Rolling 
Programme (2008/2009). Food Standards Agency and Department of Health; 2010. 
Internet: 
http://www.food.gov.uk/multimedia/pdfs/publication/ndnsreport0809year1results.pdf 
(accessed 27 February 2010). 
26. McCulloch, C., Searle, S. Generalized Linear and Mixed Models. New York: Wiley, 
2000. 
27. le Roux, C.W., Batterham, R.L., Aylwin, S.J.B., Patterson, M., Borg, C.M., Wynne, 
K.J., Kent, A., Vincent, R.P., Gardiner, J., Ghatei, M.A., et al. Attenuated peptide YY 
release in obese subjects is associated with reduced satiety. Endocrinology 2006; 
147(1):3-8. 
28. Martins, C., Robertson, M.D., Morgan, L.M. Impact of restraint and disinhibition on 
PYY plasma levels and subjective feelings of appetite. Appetite 2010; 55(2):208-213. 
29. Vilsbøll, T., Krarup, T., Sonne, J., Madsbad, S., Vølund, A., Juul, A.G., Holst, J.J. 
Incretin secretion in relation to meal size and body weight in healthy subjects and 
people with type 1 and type 2 diabetes mellitus. Journal of Clinical Endocrinology and 
Metabolism 2003; 88(6):2706-2713. 
30. Rijkelijkhuizen, J.M., McQuarrie, K., Girman, C.J., Stein, P.P., Mari, A., Holst, J.J., 
Nijpels, G., Dekker, J.M. Effects of meal size and composition on incretin, α-cell, and 
β-cell responses. Metabolism 2010; 59(4):502-511. 
22 
 
 
 
31. Borer, K.T., Wuorinen, E., Ku, K., Burant, C. Appetite Responds to Changes in Meal 
Content, Whereas Ghrelin, Leptin, and Insulin Track Changes in Energy Availability. 
Journal of Clinical Endocrinology & Metabolism 2009; 94(7):2290-2298. 
32. Blom, W.A.M., Stafleu, A., de Graaf, C., Kok, F.J., Schaafsma, G., Hendriks, H.F.J. 
Ghrelin response to carbohydrate-enriched breakfast is related to insulin. American 
Journal of Clinical Nutrition 2005; 81(2):367-375. 
33. Colman, A.M. Oxford Dictionary of Psychology. 3rd edition. Oxford: Oxford 
University Press, 2009. 
34. Flint, A., Moller, B.K., Raben, A., Sloth, B., Pedersen, D., Tetens, I., Holst, J.J., 
Astrup, A. Glycemic and insulinemic responses as determinants of appetite in humans. 
American Journal of Clinical Nutrition 2006; 84(6):1365-1373. 
35. Willbond, S.M., Doucet, E. Individually timing high-protein preloads has no effect on 
daily energy intake, peptide YY and glucagon-like peptide-1. European Journal of 
Clinical Nutrition 2011; 65(1):55-62. 
36. Verdich, C., Toubro, S., Buemann, B., Lysgård Madsen, J., Juul Holst, J., Astrup, A. 
The role of postprandial releases of insulin and incretin hormones in meal-induced 
satiety - Effect of obesity and weight reduction. International Journal of Obesity 2001; 
25(8):1206-1214. 
37. Drapeau, V., King, N., Hetherington, M., Doucet, E., Blundell, J., Tremblay, A. 
Appetite sensations and satiety quotient: Predictors of energy intake and weight loss. 
Appetite 2007; 48(2):159-166. 
38. Lemmens, S.G., Martens, E.A., Born, J.M., Martens, M.J., Westerterp-Plantenga, M.S. 
Staggered meal consumption facilitates appetite control without affecting postprandial 
energy intake. Journal of Nutrition 2011; 141(3):482-488. 
23 
 
 
 
39. Holt, S.H.A., Miller, J.C.B., Petocz, P. Interrelationships among postprandial satiety, 
glucose and insulin responses and changes in subsequent food intake. European 
Journal of Clinical Nutrition 1996; 50(12):788-797. 
40. Gray, R.W., French, S.J., Robinson, T.M., Yeomans, M.R. Dissociation of the effects 
of preload volume and energy content on subjective appetite and food intake. 
Physiology & Behavior 2002; 76(1):57-64. 
41. De Graaf, C., Hulshof, T. Effects of weight and energy content of preloads on 
subsequent appetite and food intake. Appetite 1996; 26(2):139-151. 
42. Stubbs, R.J., Hughes, D.A., Johnstone, A.M., Rowley, E., Reid, C., Elia, M., Stratton, 
R., Delargy, H., King, N., Blundell, J.E. The use of visual analogue scales to assess 
motivation to eat in human subjects: a review of their reliability and validity with an 
evaluation of new hand-held computerized systems for temporal tracking of appetite 
ratings. British Journal of Nutrition 2000; 84(4):405-415. 
43. Batterham, R.L., Cohen, M.A., Ellis, S.M., le Roux, C.W., Withers, D.J., Frost, G.S., 
Ghatei, M.A., Bloom, S.R. Inhibition of food intake in obese subjects by peptide YY3-
36. New England Journal of Medicine 2003; 349(10):941-948. 
44. Sloth, B., Holst, J.J., Flint, A., Gregersen, N.T., Astrup, A. Effects of PYY1-36 and 
PYY3-36 on appetite, energy intake, energy expenditure, glucose and fat metabolism 
in obese and lean subjects. American Journal of Physiology - Endocrinology and 
Metabolism 2007; 292(4):E1062-E1068. 
45. Brennan, I.M., Luscombe-Marsh, N.D., Seimon, R.V., Otto, B., Horowitz, M., 
Wishart, J.M., Feinle-Bisset, C. Effects of fat, protein, and carbohydrate and protein 
load on appetite, plasma cholecystokinin, peptide YY, and ghrelin, and energy intake 
in lean and obese men. American Journal of Physiology - Gastrointestinal and Liver 
Physiology 2012; 303(1):G129-G140. 
24 
 
 
 
46. Lemmens, S.G., Martens, E.A., Kester, A.D., Westerterp-Plantenga, M.S. Changes in 
gut hormone and glucose concentrations in relation to hunger and fullness. American 
Journal of Clinical Nutrition 2011; 94(3):717-725. 
47. Leidy, H.J., Apolzan, J.W., Mattes, R.D., Campbell, W.W. Food Form and Portion 
Size Affect Postprandial Appetite Sensations and Hormonal Responses in Healthy, 
Nonobese, Older Adults. Obesity 2009; 18(2):293-299. 
48. Blundell, J.E., Levin, F., King, N.A., Barkeling, B., Gustafson, T., Hellstrom, P.M., 
Holst, J.J., Naslund, E. Overconsumption and obesity: Peptides and susceptibility to 
weight gain. Regulatory Peptides 2008; 149(1-3):32-38. 
49. Gibbons, C., Caudwell, P., Finlayson, G., Webb, D.L., Hellström, P.M., Näslund, E., 
Blundell, J.E. Comparison of postprandial profiles of ghrelin, active GLP-1, and total 
PYY to meals varying in fat and carbohydrate and their association with hunger and 
the phases of satiety. Journal of Clinical Endocrinology and Metabolism 2013; 
98(5):E847-E855. 
50. Guo, Y., Ma, L.J., Enriori, P.J., Koska, J., Franks, P.W., Brookshire, T., Cowley, 
M.A., Salbe, A.D., DelParigi, A., Tataranni, P.A. Physiological evidence for the 
involvement of peptide YY in the regulation of energy homeostasis in humans. 
Obesity 2006; 14(9):1562-1570. 
51. Stock, S., Leichner, P., Wong, A.C.K., Ghatei, M.A., Kieffer, T.J., Bloom, S.R., 
Chanoine, J.P. Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, 
and hunger responses to a mixed meal in anorexic, obese, and control female 
adolescents. Journal of Clinical Endocrinology & Metabolism 2005; 90(4):2161-2168. 
52. Paschetta, E., Hvalryg, M., Musso, G. Glucose-dependent insulinotropic polypeptide: 
from pathophysiology to therapeutic opportunities in obesity-associated disorders. 
Obesity Reviews 2011; 12(10):813-828. 
25 
 
 
 
  
26 
 
 
 
Table 1: Participant characteristics. 
Mean ± SEM. 
BMI:  Body Mass Index. RMR: Resting metabolic rate. 
 
Table 2: Estimated regression coefficients to measure associations between biochemical 
measures and perceived appetite ratings (predictor variables) with energy intake at lunch and 
over the whole day apart from breakfast (outcome variables), from mixed effects models. 
AUC: area under the curve.  EI: energy intake. SE: standard error. 
Area under the curve was calculated for between the fasting and pre-lunch time points for 
predicting energy intake at lunch.  Area under the curve for the whole day was calculated for 
predicting energy intake over the whole day apart from breakfast.  Each predictor was 
analysed in a separate mixed effects model.  
Values are given to 4 significant figures.  Those in bold are significant. 
 
Table 3: Estimated regression coefficients to measure associations between biochemical 
measures (predictor variables) and perceived appetite ratings (outcome variables) from 
baseline to the pre-lunch time-point, from mixed effects models. 
SE: standard error. 
Each predictor was analysed in a separate model.  
Values are given to 4 significant figures. Those in bold are significant. 
 
Figure 1:  Overview of the time points for meals and measurements taken during a study day 
(GIP: glucose-dependent insulinotropic peptide; GLP-1: glucagon-like peptide 1; MRC HNR: 
Medical Research Council Human Nutrition Research; PYY: peptide tyrosine tyrosine; VAS: 
visual analogue scales). 
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Figure 2: Mean (± SEM) energy intake at A) lunch and B) over the whole day, not including 
breakfast, according to condition. 
Figure 3: Postprandial response (mean ± SEM) of A) plasma PYY3-36, B) plasma total GLP-
1, and C) plasma total GIP, according to condition.  Letter indicates the condition where the 
mean is significantly different at that time point (mixed effects models): p<0.05. 
Figure 4: Postprandial response of A) plasma glucose (mean ± SEM), and B) plasma insulin 
(geometric mean ± 95% confidence intervals), according to condition.  Letter indicates the 
condition where the mean is significantly different at that time point (mixed effects models): 
p<0.05. 
Figure 5: Postprandial ratings (mean ± SEM) for A) perceived hunger, B) perceived fullness, 
C) perceived desire to eat, and D) perceived prospective consumption, according to condition.  
Letter indicates the condition where the mean is significantly different at that time point 
(mixed effects models): p<0.05. 
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Table 1 
Participant characteristic 
All participants 
(n=33) 
Blood sample 
subgroup (n=20) 
Non-blood subgroup  
(n=13) 
Number of men/women 15/18 9/11 7/6 
Height (m) 1.69 ± 0.01 1.69 ± 0.01 1.71 ± 0.03 
Weight (kg) 83.8 ± 1.5 82.9 ± 2.1 85.3 ± 2.0 
BMI (kg/m2) 29.0 ± 0.4 29.0 ± 0.5 29.2 ± 0.8 
Age (years) 42.5 ± 2.0 40.8 ± 2.5 45 ± 3.4 
Dietary restraint 7.2 ± 0.7 6.5 ± 0.9 8.2 ± 1.1 
Disinhibition 6.7 ± 0.6 6.5 ± 0.7 6.9 ± 1.1 
Hunger trait 6.3 ± 0.7 6.2 ± 0.8 6.5 ± 1.1 
RMR (kJ/day) 6594 ± 160 6704 ± 224 6425 ± 220 
Fasting glucose (mmol/L) 4.8 ± 0.1 4.7 ± 0.1 4.9 ± 0.1 
Body fat (%) 32.8 ±  1.5 31.9 ± 1.8 34.2 ± 2.6 
Vigorous physical activity 
(mins per week) 65 ±  13 55 ± 14 80 ± 24 
Moderate physical activity 
(mins per week) 142 ±  21 173 ± 29 94 ± 26 
Walking (mins per week) 254 ±  30 270 ± 37 231 ± 53 
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Table 2 
 
AUC as predictor Pre-lunch measure as predictor 
Predictor of lunch EI Regression coefficient (SE) p-value 
Regression 
coefficient (SE) p-value 
Biochemical measure     
    PYY 0.029 (0.014) 0.032 4.442 (2.257) 0.049 
    GLP-1 0.019 (0.071) 0.790 15.95 (11.17) 0.154 
    GIP 2.666 (4.446) 0.549 39.08 (33.06) 0.237 
    Glucose -0.916 (0.710) 0.197 -365.5 (245.8) 0.137 
    Insulin -197.0 (259.8) 0.448 -157.0 (168.7) 0.352 
Perceived appetite rating 
        Hunger 0.091 (0.022) <0.001 11.96 (3.934) 0.002 
    Fullness -0.029 (0.017) 0.085 -10.43 (3.389) 0.002 
    Desire to eat 0.087 (0.018) <0.001 8.788 (3.783) 0.020 
    Prospective consumption 0.100 (0.022) <0.001 19.21 (4.384) <0.001 
Predictor of whole day EI Regression coefficient (SE) p-value   
AUC perceived appetite 
rating     
    Hunger 0.057 (0.025) 0.026   
    Fullness -0.016 (0.021) 0.469   
    Desire to eat 0.057 (0.023) 0.013   
    Prospective consumption 0.068 (0.025) 0.007   
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Table 3 
 Perceived appetite rating 
 Hunger Fullness Desire to eat Prospective consumption 
Biochemical measure Regression coefficient (SE) p-value 
Regression 
coefficient (SE) p-value 
Regression 
coefficient (SE) p-value 
Regression 
coefficient (SE) p-value 
PYY -0.032 (0. 038) 0.409 0.041 (0.041) 0.315 -0.018 (0.040) 0.650 -0.028 (0.031) 0.366 
GLP-1 -0.494 (0.172) 0.004 0.631 (0.186) 0.001 -0.442 (0.176) 0.012 -0.421 (0.138) 0.002 
GIP -3.271 (0.373) <0.001 3.357 (0.416) <0.001 -3.143 (0.379) <0.001 -2.629 (0.305) <0.001 
Glucose -6.650 (1.058) <0.001 6.058 (1.186) <0.001 -5.493 (1.087) <0.001 -4.396 (0.884) <0.001 
Insulin -14.07 (1.227) <0.001 14.33 (1.391) <0.001 -13.63 (1.250) <0.001 -11.86 (0.990) <0.001 
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